PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
October 4, 2013The Journal of Clinical Endocrinology & Metabolism219 citationsOpen Access

Essential Role of Estrogen for Improvements in Vascular Endothelial Function With Endurance Exercise in Postmenopausal Women

View Full Paper
KMKerrie L. MoreauVascular MedicineBSBrian L. StaufferDenver Health Medical CenterWKWendy M. KohrtNorthern Illinois University

Key Result

Endurance exercise training improved brachial artery flow-mediated dilation in postmenopausal women treated with estradiol (P<0.025), but not in those receiving placebo (P=0.55).

Study Design

Type

RCT (n=36)

Randomization

randomized

Structured PICO

Does estrogen therapy combined with endurance exercise training improve vascular endothelial function in sedentary, estrogen-deficient postmenopausal women?

P
Population
36 sedentary, estrogen-deficient postmenopausal women aged 45-65 years, randomized to placebo or estradiol for 12 weeks followed by 12 weeks of concurrent endurance exercise training.
I
Intervention
Oral (1 mg/d) estradiol or transdermal estradiol (0.05 mg/d) for 12 weeks, followed by an additional 12 weeks of continued estradiol treatment with concurrent endurance exercise training.
C
Comparator
Placebo for 12 weeks, followed by an additional 12 weeks of continued placebo treatment with concurrent endurance exercise training.
O
Outcome
Brachial artery flow-mediated dilation (FMD)surrogate

Estrogen therapy restores the ability of endurance exercise training to improve endothelial function in postmenopausal women, potentially by mitigating oxidative stress.

Main Result

p-value: p=<.025

Abstract

OBJECTIVE: In contrast to age-matched men, endurance exercise training is not consistently associated with enhanced endothelial function in estrogen-deficient postmenopausal women. We determined whether endurance exercise training improves endothelial function in postmenopausal women treated with estrogen. In a substudy, we determined if oxidative stress is mechanistically linked to endothelial function adaptations to endurance exercise training. PARTICIPANTS AND DESIGN: Brachial artery flow-mediated dilation (FMD) was measured in 36 sedentary, estrogen-deficient postmenopausal women (45-65 y) at study entry (baseline), after 12 weeks of either placebo, oral (1 mg/d) estradiol, or transdermal estradiol (0.05 mg/d) (randomized), and after an additional 12 weeks of continued estradiol or placebo treatment with concurrent endurance exercise training. In subgroups of women, FMD also was measured during the infusion of ascorbic acid at baseline and following estradiol/placebo plus endurance exercise training, and in seven habitually endurance-trained estrogen-deficient controls. RESULTS: FMD increased in the estrogen-treated groups (both P < .01) after 12 weeks and remained unchanged in placebo. FMD further increased following 12 weeks of endurance exercise training in estrogen-treated (both P < .025), but not placebo-treated women (P = .55). In the substudy, baseline FMD was similar between sedentary and endurance-trained controls. Ascorbic acid increased FMD at baseline in sedentary women and endurance-trained controls, and following endurance exercise training in placebo-treated, but not in estrogen-treated women. CONCLUSIONS: Estrogen status appears to play an important modulatory role in improvements in endothelial function with endurance exercise training in postmenopausal women. The restored endurance exercise training adaptation in estrogen-treated postmenopausal women may be related to mitigation of oxidative stress.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Moreau et al. (2013) conducted an RCT in Estrogen deficiency in postmenopausal women (n=36). Estradiol plus endurance exercise training vs. Placebo plus endurance exercise training was evaluated on Brachial artery flow-mediated dilation (FMD) (p=<.025). Endurance exercise training improved brachial artery flow-mediated dilation in postmenopausal women treated with estradiol (P<0.025), but not in those receiving placebo (P=0.55).

synapsesocial.com/papers/6a225ef5ead6bb8ea577abe7https://doi.org/10.1210/jc.2013-2183
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Heart Disease and Stroke Statistics—2011 Update2010 · 6,177 citations
  2. 2Tetrahydrobiopterin improves endothelial function and decreases arterial stiffness in estrogen-deficient postmenopausal women2012 · 97 citations
  3. 3Time Since Menopause Influences the Acute and Chronic Effect of Estrogens on Endothelial Function2007 · 96 citations
  4. 4Vascular cell signaling by membrane estrogen receptors2008 · 154 citations
  5. 5Estrogen receptor-α gene transfer into bovine aortic endothelial cells induces eNOS gene expression and inhibits cell migration1999 · 70 citations